Viemed Healthcare
VMD
35 hedge funds and large institutions have $84.7M invested in Viemed Healthcare in 2019 Q3 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
32.45% more ownership
Funds ownership: 0% → 32.45% (+32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
+$16.4M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$9.98M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$9.82M |
| 4 |
AIC
AWM Investment Company
New York
|
+$6.93M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.11M |
Top Sellers
VMD Hedge Fund Activity: Q3 2019 in Review
35 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2019, worth a combined $84.7M.
Buyers outnumbered sellers: 35 funds opened new VMD positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Claret Asset Management, opening a new position worth an estimated $16.4M.
- 35 institutional investors held Viemed Healthcare (VMD) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $84.7M of Viemed Healthcare stock for Q3 2019.
- 35 funds opened new Viemed Healthcare positions in Q3 2019 and 0 closed out, a net change of +35 holders.
- The largest Viemed Healthcare buyer in Q3 2019 was Claret Asset Management, an estimated $16.4M added.
Based on aggregated 13F filings for Q3 2019.